Intravenous administration of Reolysin®, a live replication competent RNA virus is safe in patients with advanced solid tumors.

Autor: Gollamudi R, Ghalib MH, Desai KK, Chaudhary I, Wong B, Einstein M, Coffey M, Gill GM, Mettinger K, Mariadason JM, Mani S, Goel S

Publikováno v: Investigational New Drugs; Oct2010, Vol. 28 Issue 5, p641-649, 9p

9-cis retinoic acid induces complete remission but does not reverse clinically acquired retinoid resistance in acute promyelocytic leukemia

Autor: Miller, WH Jr, Jakubowski, A, Tong, WP, Miller, VA, Rigas, JR, Benedetti, F, Gill, GM, Truglia, JA, Ulm, E, Shirley, M

Publikováno v: Blood; June 1995, Vol. 85 Issue: 11 p3021-3027, 7p

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Oncolytic reovirus in combination with chemotherapy in metastatic or recurrent non-small cell lung cancer patients with KRAS-activated tumors.

Autor: Villalona-Calero MA; Division of Medical Oncology, Department of Internal Medicine, Ohio State University Comprehensive Cancer Center, Columbus, Ohio., Lam E; Division of Medical Oncology, Department of Internal Medicine, Ohio State University Comprehensive Cancer Center, Columbus, Ohio., Otterson GA; Division of Medical Oncology, Department of Internal Medicine, Ohio State University Comprehensive Cancer Center, Columbus, Ohio., Zhao W; Department of Pathology, Ohio State University Comprehensive Cancer Center, Columbus, Ohio., Timmons M; Ohio State University Comprehensive Cancer Center, Columbus, Ohio., Subramaniam D; Lombardi Cancer Center, Georgetown University, Washington, DC., Hade EM; Center for Biostatistics, Department of Biomedical Informatics, Ohio State University Comprehensive Cancer Center, Columbus, Ohio., Gill GM; Oncolytics Biotech, Incorporated, Calgary, Canada., Coffey M; Oncolytics Biotech, Incorporated, Calgary, Canada., Selvaggi G; Oncolytics Biotech, Incorporated, Calgary, Canada., Bertino E; Division of Medical Oncology, Department of Internal Medicine, Ohio State University Comprehensive Cancer Center, Columbus, Ohio., Chao B; Division of Medical Oncology, Department of Internal Medicine, Ohio State University Comprehensive Cancer Center, Columbus, Ohio., Knopp MV; Department of Radiology, Ohio State University Comprehensive Cancer Center, Columbus, Ohio.

Publikováno v: Cancer [Cancer] 2016 Mar 15; Vol. 122 (6), pp. 875-83. Date of Electronic Publication: 2015 Dec 28.

Phase 1 clinical trial of intratumoral reovirus infusion for the treatment of recurrent malignant gliomas in adults.

Autor: Kicielinski KP; Department of Surgery, Division of Neurosurgery, University of Alabama, Birmingham, Birmingham, Alabama, USA., Chiocca EA; Department of Neurosurgery, Brigham and Women's Hospital, Boston, Massachusetts, USA., Yu JS; Department of Neurosurgery, Cedars-Sinai, West Hollywood, California, USA., Gill GM; Oncolytics Biotech, Calgary, Alberta, Canada., Coffey M; Oncolytics Biotech, Calgary, Alberta, Canada., Markert JM; Department of Surgery, Division of Neurosurgery, University of Alabama, Birmingham, Birmingham, Alabama, USA.

Publikováno v: Molecular therapy : the journal of the American Society of Gene Therapy [Mol Ther] 2014 May; Vol. 22 (5), pp. 1056-62. Date of Electronic Publication: 2014 Feb 20.